These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 22294590

  • 1. Theory and practice of conventional adventitious virus testing.
    Gregersen JP.
    PDA J Pharm Sci Technol; 2011; 65(6):634-44. PubMed ID: 22294590
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification and remediation of a cell culture virus contamination.
    Jones N.
    PDA J Pharm Sci Technol; 2011; 65(6):615. PubMed ID: 22294585
    [Abstract] [Full Text] [Related]

  • 5. Case study of apparent virus contamination in biopharmaceutical product at centocor.
    Hendricks LC, Vacante DA.
    PDA J Pharm Sci Technol; 2011; 65(6):612-3. PubMed ID: 22294583
    [Abstract] [Full Text] [Related]

  • 6. Current European regulations for control of adventitious virus safety.
    Blümel J.
    PDA J Pharm Sci Technol; 2011; 65(6):568-79. PubMed ID: 22294579
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Application of quality by design in the control of adventitious viruses: gaps in current processes in the prevention of virus contaminants.
    Cherney B.
    PDA J Pharm Sci Technol; 2011; 65(6):754-66. PubMed ID: 22294609
    [Abstract] [Full Text] [Related]

  • 10. PDA Cell Substrate Task Force: Emerging Technologies for Virus Detection Technical Document--A Progress Report.
    King K, Wiebe M.
    PDA J Pharm Sci Technol; 2011; 65(6):693. PubMed ID: 22294602
    [Abstract] [Full Text] [Related]

  • 11. A biotech production facility contamination case study--minute mouse virus.
    Skrine J.
    PDA J Pharm Sci Technol; 2011; 65(6):599-611. PubMed ID: 22294582
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Practicing safe cell culture: applied process designs for minimizing virus contamination risk.
    Kiss RD.
    PDA J Pharm Sci Technol; 2011; 65(6):715-29. PubMed ID: 22294606
    [Abstract] [Full Text] [Related]

  • 15. Overview of emerging technologies to detect adventitious agents.
    Onions D.
    PDA J Pharm Sci Technol; 2011; 65(6):654-9. PubMed ID: 22294592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Viral Safety of Plasma-derived Products.
    Farshid M.
    PDA J Pharm Sci Technol; 2011; 65(6):737-53. PubMed ID: 22294608
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Summary of breakout session e.
    Brorson K, Lubiniecki A.
    PDA J Pharm Sci Technol; 2011; 65(6):616-9. PubMed ID: 22294586
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.